Plain-English translation of NCT07501377 on ClinicalTrials.gov โ ยท Source last updated ยท Translation generated ยท How we translate trials
This study doesn't follow the usual testing phases โ it may be an observational study or a different type of research.
This trial is testing whether a personalized daily powder formula containing inulin (a plant fiber), resveratrol, and quercetin (plant compounds) can help protect brain health in women during the perimenopausal transition who are living with overweight or obesity. The medication works by changing the balance of bacteria in your gut, which scientists believe may reduce inflammation in both your body and brain. Half of participants will receive the active formula, and half will receive a placebo powder with no active ingredients, over six months.
Women with obesity face a higher risk of memory loss and dementia, especially during midlife hormonal changes. Recent research suggests that what we eat can change our gut bacteria in ways that reduce harmful inflammation and protect the brain, but we need more evidence from human studies to understand how this works and whether it actually helps.
You likely qualify ifโฆ
You likely don't qualify ifโฆ
You will visit the research center before the study begins and again after six months for brain scans (MRI) and thinking tests. Throughout the six months, you will take a daily powder (either the active formula or placebo) mixed with your main meals, and complete questionnaires about your health and well-being. You may also have blood tests and body measurements taken at the start and end of the study.
AI-generated summary from trial data ยท Jun 13, 2026 ยท Not medical advice
Germany